Anixa Biosciences, Inc.
Anixa Biosciences, Inc. scores highest on Torque (55) and lowest on Price (11). Its PosiPenta is 41.53 out of 100, around the middle of similar companies.
On the Penta Grid this week, Anixa Biosciences, Inc. is Grid #483 of 837 in the Healthcare sector in United States, and Grid #2,728 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Anixa Biosciences, Inc. | 41.53 | 11 | 46 | 42 | 55 | 54 |
| Polaryx Therapeutics, Inc. | 40.50 | 8 | 72 | 4 | 59 | 60 |
| Park Dental Partners, Inc. | 51.60 | 22 | 73 | 73 | 37 | 54 |
| Coya Therapeutics, Inc. | 45.28 | 26 | 28 | 49 | 65 | 58 |
| NeurAxis, Inc. | 48.34 | 5 | 59 | 86 | 41 | 50 |
| Vivani Medical, Inc. | 34.40 | 13 | 45 | 53 | 16 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -8.34 |
| P/B ratio | 6.41 |
EEarnings
| Trailing EPS | ₹-30.31 |
| Forward EPS | ₹-29.36 |
NNitro
| Price | 252.89 |
| 52-week high | 517.14 |
| 52-week low | 219.74 |
| Fall from 52-week high | 51.1% |
TTorque
| Return on equity (ROE) | -73.17% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.48 |
| Market cap | ₹879 Cr |
| Insider holding | 5.62% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Anixa Biosciences, Inc.'s PosiPenta score?
Anixa Biosciences, Inc.'s PosiPenta is 41.53 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Anixa Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Anixa Biosciences, Inc. is Grid #483 of 837 in the Healthcare sector in United States, and Grid #2,728 of 4,000 in United States.
Which PosiPenta pillar is strongest for Anixa Biosciences, Inc.?
Torque (durability), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Anixa Biosciences, Inc.?
Price (valuation), with a score of 11 out of 100: much weaker than most similar companies.
Has Anixa Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.01 points, from 37.52 to 41.53.
PositoAI is for research and education only and is not investment advice.